The Enterprise Value as of November 2024 (TTM) for Dr. Reddy's Laboratories Limited (RDY) is 1.03T

According to Dr. Reddy's Laboratories Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.03T. This represents a change of 490.65% compared to the average of 174.90B of the last 4 quarters.

Dr. Reddy's Laboratories Limited (RDY) Historical Enterprise Value (quarterly & annually)

How has RDY Enterprise Value performed in the past?

The mean historical Enterprise Value of Dr. Reddy's Laboratories Limited over the last ten years is 141.14B. The current 1.03T Enterprise Value has changed 73.09% with respect to the historical average. Over the past ten years (40 quarters), RDY's Enterprise Value was at its highest in in the June 2024 quarter at 235.36B. The Enterprise Value was at its lowest in in the September 2024 quarter at 37.21B.

Dr. Reddy's Laboratories Limited (RDY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dr. Reddy's Laboratories Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dr. Reddy's Laboratories Limited (RDY) Average Enterprise Value

How has RDY Enterprise Value performed in the past?

The current Enterprise Value of Dr. Reddy's Laboratories Limited (RDY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dr. Reddy's Laboratories Limited (RDY) Enterprise Value vs. Peers

How is RDY’s Enterprise Value compared to its peers?

Dr. Reddy's Laboratories Limited’s Enterprise Value is greater than Pacira BioSciences, Inc. (1.17B), greater than Phibro Animal Health Corporation (1.20B), greater than Collegium Pharmaceutical, Inc. (1.84B), greater than Silver Spike Investment Corp. (33.56M), greater than ANI Pharmaceuticals, Inc. (1.70B), greater than Alkermes plc (4.70B), greater than Intra-Cellular Therapies, Inc. (8.72B), greater than Eagle Pharmaceuticals, Inc. (24.91M), greater than Prestige Consumer Healthcare Inc. (5.12B), greater than Evotec SE (1.38B), greater than Supernus Pharmaceuticals, Inc. (2.00B), greater than Deciphera Pharmaceuticals, Inc. (2.15B),

Build a custom stock screener for Dr. Reddy's Laboratories Limited (RDY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dr. Reddy's Laboratories Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dr. Reddy's Laboratories Limited (RDY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dr. Reddy's Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.